Canada Markets closed

Applied Therapeutics, Inc. (APLT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.3300+0.1600 (+5.05%)
At close: 04:00PM EST
3.1200 -0.21 (-6.31%)
After hours: 04:16PM EST
Sign in to post a message.
  • b
    bluehorseshoe999
    Most likely scenario is as follows:

    1. Complete P3 data so far get reported in Feb/March time frame.
    2a. Results are fantastic and thus, company goes to prepare for NDA in the fall
    2b. Additional fund are raised with PPS popping around 20 in preparation for NDA and continuing trials
    3. Continue trials to add to current data to NDA submission in the fall
    4. Drug gets PFUDA date some time in the middle of 2023 for approval...
    5. Drug gets approved.

    Fly in the ointment for shorts is that when new capital is raised PPS would have jumped significantly from current levels so covering with new issued shares would not be profitable. Big loss and a Big gamble in shorting here with all the good data so far on the drug!

    GLTA in stock casino!
  • b
    bluehorseshoe999
    Quite interesting!!!!

    Here is an excerpt from company PR:

    The ongoing ACTION-Galactosemia Kids Phase 3 study is evaluating the impact of AT-007 treatment vs. placebo on clinical outcomes over time, including cognition, speech, behavior and motor skills. Clinical outcomes are assessed every 6 months by a firewalled committee. The first assessment will be completed in the first quarter of 2022, and then every 6 months thereafter until the study reaches statistical significance.

    First assessment will be 1Q2022. Probably some time in March. If past data are any indication then it should be good results. Just have to wait and see and then every 6 months....

    Only have to wait about 2 months for first inkling on P3 data...

    GLTA in stock casino!
  • s
    stocktracker000
    BTW, strong support today at 6.10 or so...
  • G
    Gotham
    now seems like an exciting time to buy this bargain
  • A
    Andreas
    will this survive?
  • s
    stocktracker000
    It will be long time before the drug gets approved. Complete P3 with all the safety profile is being asked by FDA...

    Clinical trials cost money so company will burn more cash this year to get LT safety data that FDA wants...

    I see more capital raise in 1-2 years since company is burning about 100M a year and has 100M cash....

    Good Luck to and do your due diligence always....
  • Y
    Yahoo Finance Insights
    Applied Therapeutics reached an all time low at 2.99
  • Y
    Yahoo Finance Insights
    Applied Therapeutics reached an all time low at 3.30
  • s
    stocktracker000
    Looks like we will finish below 6....

    This time it is for real considering same delay was announced in Sept 21....

    Large volume and steady drop in price...

    Until good news comes out, cash burn and agony will continue...

    Good Luck to and do your due diligence always....
  • Y
    Yahoo Finance Insights
    Applied Therapeutics reached an all time low at 3.51
  • s
    stocktracker000
    Mt target for this stock is 5 but it won't get there....

    I am sure institutions will show up around 5.05 or so and scoop up shares to keep it out of penny territory...

    Good Luck to and do your due diligence always....
  • Y
    Yahoo Finance Insights
    Applied Therapeutics reached an all time low at 3.77
  • Y
    Yahoo Finance Insights
    Applied Therapeutics is down 13.92% to 5.01
  • Y
    Yahoo Finance Insights
    Applied Therapeutics is down 27.37% to 6.50
  • b
    bluehorseshoe999
    Looks bad low of 4.33!

    Wonder how long the delay for NDA is going to be. AT this point indeterminate!

    GLTA in stock casino!
  • C
    Casablanca
    it has lost more than 50% in few months. why ?
  • S
    Stupid Redd
    not looking good in at $6
  • s
    stocktracker000
    More delays...

    Nothing more need to be said...

    Good Luck to and do your due diligence always....
  • Y
    Yahoo Finance Insights
    Applied Therapeutics reached an all time low at 4.00
  • Y
    Yahoo Finance Insights
    Applied Therapeutics reached an all time low at 3.56